Gülşah Akdemir
0000-0002-9560-7010
2 papers found
Refreshing results…
Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis
Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study)
Missing publications? Search for publications with a matching author name.